Go to North America site
Login
Deutsch
German
de
English
English
en
COMPANY
ABOUT US
Sustainability
History
TEAM
Management
Supervisory Board
CAREER
Congresses & Courses
ORTHOPEDICS
FIELDS OF APPLICATIONS
Osteoarthritis Therapy
Bone Regeneration
Wound Healing
PRODUCTS
CERASORB®
stypro®
Curavisc®
Ceracell®
PUBLICATIONS
Literature
Brochures
Patient Brochures
Case Reports
DISTRIBUTORS
DENTISTRY
FIELDS OF APPLICATIONS
Bone Regeneration
Wound Healing
PRODUCTS
CERASORB®
stypro
®
OSBONE®
Foils/Membranes
Accessories
PUBLICATIONS
Literature
Brochures
Patient Brochures
Case Reports
DISTRIBUTORS
INVESTORS
SHARE
Equity Story
Share Price
Key Share Figures
Analysts
Fact Sheet
IR Contact
IR Distribution List
PUBLICATIONS
Ad Hoc and Corporate News
Financial Reports
Financial Ratios
Presentations
Fact Sheet
Capital Increase
Archive
FINANCIAL CALENDAR
CORPORATE GOVERNANCE
Declaration of Compliance
Whistleblowing System
Code of Conduct
Managers’ Transactions
Voting Rights Notifications
Managing Board
Supervisory Board
Statute
NEWS
PUBLICATIONS
Medical Press
Corporate News
News Archive
MEDIA SERVICE
Logos
Media Contact
Search
Product Segment
Dentistry
Products for Bone Regeneration,
Foils and Membranes
Regenerative Therapies
for Bone, Cartilage and Tissue
Product Segment
Orthopedics
The controlled, minimally invasive sinus lift with the JEDER® System
Investor Relations
more Information
Spinevisc® – 3D Animation
Current share price information
The curasan Share
more Information
curasan Newsletter
Subscribe now
curasan AG: curasan AG and Donau Invest Vienna, agree on a restructuring concept by an insolvency plan
25. June 2020
/
by Andrea Weidner
curasan AG: Notification of a loss amounting to half of the equity capital in accordance with § 92 (1) AktG
17. June 2020
/
by Andrea Weidner
Diese Website benutzt Cookies. Wenn Sie die Website weiter nutzen, stimmen Sie der Verwendung von Cookies zu.
Akzeptieren
Scroll to top
